nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment
|
Zhang, Guan-Xuan-Zi |
|
|
52 |
3 |
p. 787-800 |
artikel |
2 |
A global systematic evidence review with meta-analysis of the epidemiological characteristics of the 2022 Mpox outbreaks
|
Okoli, George N. |
|
|
52 |
3 |
p. 901-921 |
artikel |
3 |
Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysis
|
Wang, Jianglin |
|
|
52 |
3 |
p. 891-899 |
artikel |
4 |
Antibiotic use in children hospitalised for influenza, 2010–2021: the Canadian Immunization Monitoring Program Active (IMPACT)
|
Schober, Tilmann |
|
|
52 |
3 |
p. 865-875 |
artikel |
5 |
Antibiotic use in pediatric acute care hospitals: an analysis of antibiotic consumption data from Germany, 2013–2020
|
Freudenhammer, Mirjam |
|
|
52 |
3 |
p. 825-837 |
artikel |
6 |
A variant of KSHV-associated inflammatory cytokine syndrome in elderly men of Mediterranean descent
|
Liapis, Konstantinos |
|
|
52 |
3 |
p. 1175-1180 |
artikel |
7 |
Burden of Candida-related vascular graft infection: a nested-case control study
|
Caulier, Thomas |
|
|
52 |
3 |
p. 1153-1158 |
artikel |
8 |
Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature review
|
Vanneste, Dorian |
|
|
52 |
3 |
p. 1113-1123 |
artikel |
9 |
Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-up
|
Triebelhorn, J. |
|
|
52 |
3 |
p. 1143-1151 |
artikel |
10 |
Clinical correlates of circulating small dense low-density lipoproteins in acute infective endocarditis
|
Boccia, Filomena |
|
|
52 |
3 |
p. 935-944 |
artikel |
11 |
Clinical evaluation of a multiplex droplet digital PCR for pathogen detection in critically ill COVID-19 patients with bloodstream infections
|
Li, Yanbing |
|
|
52 |
3 |
p. 1027-1039 |
artikel |
12 |
Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era
|
Götz, Veronika |
|
|
52 |
3 |
p. 923-933 |
artikel |
13 |
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study
|
Doua, Joachim |
|
|
52 |
3 |
p. 1073-1085 |
artikel |
14 |
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
|
Lahmer, Tobias |
|
|
52 |
3 |
p. 1191-1194 |
artikel |
15 |
Cutaneous involvement as an initial presentation of disseminated cryptococcosis in a renal allograft recipient
|
Tirlangi, Praveen Kumar |
|
|
52 |
3 |
p. 1189-1190 |
artikel |
16 |
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine
|
Calcagno, A. |
|
|
52 |
3 |
p. 737-765 |
artikel |
17 |
Early combination therapy of COVID-19 in high-risk patients
|
Orth, Hans Martin |
|
|
52 |
3 |
p. 877-889 |
artikel |
18 |
Emergence of Campylobacter fetus bacteraemias in the last decade, France
|
Zayet, Souheil |
|
|
52 |
3 |
p. 1185-1187 |
artikel |
19 |
Flucloxacillin and cefazolin for treatment of Staphylococcus aureus bloodstream infection
|
Schmidt-Hellerau, Kirsten |
|
|
52 |
3 |
p. 1159-1163 |
artikel |
20 |
High prevalence of pneumocystis pneumonia in interstitial lung disease: a retrospective study
|
Liu, Ling |
|
|
52 |
3 |
p. 985-993 |
artikel |
21 |
IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination
|
Muñoz-Gómez, María José |
|
|
52 |
3 |
p. 813-824 |
artikel |
22 |
Impaired immune responses and prolonged viral replication in lung allograft recipients infected with SARS-CoV-2 in the early phase after transplantation
|
Glueck, Olaf M. |
|
|
52 |
3 |
p. 847-855 |
artikel |
23 |
Indicator-condition-guided HIV testing in rural DRC
|
Migaud, Pascal |
|
|
52 |
3 |
p. 1171-1174 |
artikel |
24 |
Lack of microbiological awareness on the ward as a key factor for inappropriate use of anti-infectives: results of a point prevalence study and user satisfaction survey in a large university hospital in Austria
|
Kern, Jan Marco |
|
|
52 |
3 |
p. 995-1008 |
artikel |
25 |
Limited protection of pneumococcal vaccines against emergent Streptococcus pneumoniae serotype 14/ST876 strains
|
Lan, Yinle |
|
|
52 |
3 |
p. 801-811 |
artikel |
26 |
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
|
Lahmer, Tobias |
|
|
52 |
3 |
p. 1125-1141 |
artikel |
27 |
Outbreak of severe community-acquired bacterial infections among children in North Rhine-Westphalia (Germany), October to December 2022
|
Goretzki, Sarah C. |
|
|
52 |
3 |
p. 1099-1111 |
artikel |
28 |
Persistent immune abnormalities discriminate post-COVID syndrome from convalescence
|
Sbierski-Kind, Julia |
|
|
52 |
3 |
p. 1087-1097 |
artikel |
29 |
Preventable deaths involving sepsis in England and Wales, 2013–2022: a systematic case series of coroners’ reports
|
Jindal, Jessy |
|
|
52 |
3 |
p. 945-954 |
artikel |
30 |
Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials
|
Abuelazm, Mohamed T. |
|
|
52 |
3 |
p. 707-722 |
artikel |
31 |
Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns
|
Steinmann, Maren |
|
|
52 |
3 |
p. 1009-1026 |
artikel |
32 |
Safety and efficacy of non-reduced use of caspofungin in patients with Child–Pugh B or C cirrhosis: a real-world study
|
Yuan, Shi-Dan |
|
|
52 |
3 |
p. 1063-1072 |
artikel |
33 |
Safety and outcome of treatment of latent tuberculosis infection in liver transplant recipients
|
Lee, Yun Woo |
|
|
52 |
3 |
p. 1055-1061 |
artikel |
34 |
SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants
|
Hattab, Dima |
|
|
52 |
3 |
p. 767-786 |
artikel |
35 |
SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19
|
Wang, Ying‑Chuan |
|
|
52 |
3 |
p. 955-983 |
artikel |
36 |
Sepsis mimics among presumed sepsis patients at intensive care admission: a retrospective observational study
|
Lengquist, Maria |
|
|
52 |
3 |
p. 1041-1053 |
artikel |
37 |
Successful treatment of glandular tularemia with azithromycin in a pregnant woman in Austria
|
Schubert, Lorenz |
|
|
52 |
3 |
p. 1181-1184 |
artikel |
38 |
The role of gut barrier dysfunction in postoperative complications in liver transplantation: pathophysiological and therapeutic considerations
|
Assimakopoulos, Stelios F. |
|
|
52 |
3 |
p. 723-736 |
artikel |
39 |
Trends, clinical characteristics, antimicrobial susceptibility patterns, and outcomes of Campylobacter bacteraemia: a multicentre retrospective study
|
Baek, Yae Jee |
|
|
52 |
3 |
p. 857-864 |
artikel |
40 |
Tularemia on the rise in Switzerland? A one health approach is needed!
|
Buettcher, Michael |
|
|
52 |
3 |
p. 1165-1169 |
artikel |
41 |
Viral lumbosacral radiculitis (Elsberg syndrome) in Denmark
|
Petersen, Pelle Trier |
|
|
52 |
3 |
p. 839-846 |
artikel |